COMMUNIQUÉS West-GlobeNewswire

-
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
09/05/2024 -
VitalHub Corp. Reports First Quarter 2024 Financial Results
09/05/2024 -
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
09/05/2024 -
Nova Leap Health Corp. Posts Q1 2024 Results
09/05/2024 -
Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus
09/05/2024 -
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
09/05/2024 -
23andMe to Report Q4 and Full Year FY2024 Financial Results
09/05/2024 -
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
09/05/2024 -
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
09/05/2024 -
Theratechnologies Reports on its Annual Meeting of Shareholders
09/05/2024 -
Theratechnologies rend compte de son assemblée annuelle des actionnaires
09/05/2024 -
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024
09/05/2024 -
DBV Technologies to Participate in Upcoming Investor Conferences
09/05/2024 -
Participation de DBV Technologies aux conférences investisseurs en mai
09/05/2024 -
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
09/05/2024 -
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
09/05/2024 -
AMN Healthcare Announces First Quarter 2024 Results
09/05/2024 -
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
09/05/2024 -
Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations
09/05/2024
Pages